ReachMD
CME/CE
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
Mindenképp látogasd meg a podcast oldalát, és támogasd a készítőjét: reachmd.com
Hol hallgathatod?
Podcastok az alkalmazásban Replaio Radio HamarosanA podcastok hamarosan megérkeznek az alkalmazásba. Telepítsd most, és láss elsőként egy teljesen új megközelítést a podcastokhoz
Telepítsd ingyen
Android közel 10 M letöltés · 4,8-as értékelés
iOS hamarosan
Epizódok
Chairperson’s Perspective: CDK 4/6 Inhibitors: Practice-Changing Implications of Targeted Therapies in HR+/HER2- Breast Cancer 31.12.2023 31:30
Guest: Joyce O'Shaughnessy, MD By 2040, the global breast cancer burden is expected to increase by 40%, resulting in more than 3 million new cases and 1 million deaths per year. Approximately 65% of cases among women less than 50 years of age and 75% of cases among women over 50 years of age are classified as HR+/HER2-. Although endocrine therapy is employed as standard-of-care treatment for...
Should We Look for Gout in the Cardiology Clinic? 24.10.2023 4:00
Host: Richard Johnson, MD Guest: Brittany Weber, MD, PhD This activity is no longer available for continuing education credit. Conventional oral urate-lowering therapies frequently to fail to achieve target serum uric acid (sUA) levels in patients with chronic kidney disease and uncontrolled refractory gout. This can lead to increased urate burden and complications, including worsening kidney dise...
What Are the Emerging Therapies for Managing Gout? 24.10.2023 5:00
Host: Richard Johnson, MD Guest: John K. Botson, MD, RPh This activity is no longer available for continuing education credit. Conventional oral urate-lowering therapies frequently to fail to achieve target serum uric acid (sUA) levels in patients with chronic kidney disease and uncontrolled refractory gout. This can lead to increased urate burden and complications, including worsening kidney dise...
What’s New About Gout? Rheumatology Perspective 24.10.2023 5:00
Host: Richard Johnson, MD Guest: John K. Botson, MD, RPh This activity is no longer available for continuing education credit. Conventional oral urate-lowering therapies frequently to fail to achieve target serum uric acid (sUA) levels in patients with chronic kidney disease and uncontrolled refractory gout. This can lead to increased urate burden and complications, including worsening kidney dise...
What’s New About Gout? Nephrology Perspective 24.10.2023 5:00
Host: Abdul Abdellatif, MD, FASN Guest: Richard Johnson, MD This activity is no longer available for continuing education credit. Conventional oral urate-lowering therapies frequently to fail to achieve target serum uric acid (sUA) levels in patients with chronic kidney disease and uncontrolled refractory gout. This can lead to increased urate burden and complications, including worsening kidney d...
Can You Manage Patients With Uncontrolled Gout More Effectively? 24.10.2023 5:00
Host: Abdul Abdellatif, MD, FASN Guest: John K. Botson, MD, RPh This activity is no longer available for continuing education credit. Conventional oral urate-lowering therapies frequently to fail to achieve target serum uric acid (sUA) levels in patients with chronic kidney disease and uncontrolled refractory gout. This can lead to increased urate burden and complications, including worsening kidn...
Treat or Refer: Who Is Responsible for Managing Gout? 24.10.2023 5:00
Host: John K. Botson, MD, RPh Guest: Abdul Abdellatif, MD, FASN This activity is no longer available for continuing education credit. Conventional oral urate-lowering therapies frequently to fail to achieve target serum uric acid (sUA) levels in patients with chronic kidney disease and uncontrolled refractory gout. This can lead to increased urate burden and complications, including worsening kidn...
Center of the Target: Which Patients Are Most Likely to Develop Gout? 24.10.2023 5:00
Host: Richard Johnson, MD Guest: Abdul Abdellatif, MD, FASN This activity is no longer available for continuing education credit. Conventional oral urate-lowering therapies frequently to fail to achieve target serum uric acid (sUA) levels in patients with chronic kidney disease and uncontrolled refractory gout. This can lead to increased urate burden and complications, including worsening kidney d...
Is Managing Gout in the Nephrology Clinic a Challenge? 24.10.2023 4:30
Host: Richard Johnson, MD Guest: Abdul Abdellatif, MD, FASN This activity is no longer available for continuing education credit. Conventional oral urate-lowering therapies frequently to fail to achieve target serum uric acid (sUA) levels in patients with chronic kidney disease and uncontrolled refractory gout. This can lead to increased urate burden and complications, including worsening kidney d...
Is Gout Hiding in the Nephrology Clinic? 24.10.2023 5:00
Host: Abdul Abdellatif, MD, FASN Guest: Richard Johnson, MD This activity is no longer available for continuing education credit. Conventional oral urate-lowering therapies frequently to fail to achieve target serum uric acid (sUA) levels in patients with chronic kidney disease and uncontrolled refractory gout. This can lead to increased urate burden and complications, including worsening kidney d...
Gout Beyond the Joints: What’s the Hidden Danger? 24.10.2023 3:30
Host: Richard Johnson, MD This activity is no longer available for continuing education credit. Conventional oral urate-lowering therapies frequently to fail to achieve target serum uric acid (sUA) levels in patients with chronic kidney disease and uncontrolled refractory gout. This can lead to increased urate burden and complications, including worsening kidney disease, cardiovascular events, and...
Should We Look for Gout in the Cardiology Clinic? 24.10.2023 4:00
Host: Richard Johnson, MD Guest: Brittany Weber, MD, PhD This activity is no longer available for continuing education credit. Conventional oral urate-lowering therapies frequently to fail to achieve target serum uric acid (sUA) levels in patients with chronic kidney disease and uncontrolled refractory gout. This can lead to increased urate burden and complications, including worsening kidney dise...
What Are the Emerging Therapies for Managing Gout? 24.10.2023 5:00
Host: Richard Johnson, MD Guest: John K. Botson, MD, RPh This activity is no longer available for continuing education credit. Conventional oral urate-lowering therapies frequently to fail to achieve target serum uric acid (sUA) levels in patients with chronic kidney disease and uncontrolled refractory gout. This can lead to increased urate burden and complications, including worsening kidney dise...
What’s New About Gout? Rheumatology Perspective 24.10.2023 5:00
Host: Richard Johnson, MD Guest: John K. Botson, MD, RPh This activity is no longer available for continuing education credit. Conventional oral urate-lowering therapies frequently to fail to achieve target serum uric acid (sUA) levels in patients with chronic kidney disease and uncontrolled refractory gout. This can lead to increased urate burden and complications, including worsening kidney dise...
What’s New About Gout? Nephrology Perspective 24.10.2023 5:00
Host: Abdul Abdellatif, MD, FASN Guest: Richard Johnson, MD This activity is no longer available for continuing education credit. Conventional oral urate-lowering therapies frequently to fail to achieve target serum uric acid (sUA) levels in patients with chronic kidney disease and uncontrolled refractory gout. This can lead to increased urate burden and complications, including worsening kidney d...
Can You Manage Patients With Uncontrolled Gout More Effectively? 24.10.2023 5:00
Host: Abdul Abdellatif, MD, FASN Guest: John K. Botson, MD, RPh This activity is no longer available for continuing education credit. Conventional oral urate-lowering therapies frequently to fail to achieve target serum uric acid (sUA) levels in patients with chronic kidney disease and uncontrolled refractory gout. This can lead to increased urate burden and complications, including worsening kidn...
Treat or Refer: Who Is Responsible for Managing Gout? 24.10.2023 5:00
Host: John K. Botson, MD, RPh Guest: Abdul Abdellatif, MD, FASN This activity is no longer available for continuing education credit. Conventional oral urate-lowering therapies frequently to fail to achieve target serum uric acid (sUA) levels in patients with chronic kidney disease and uncontrolled refractory gout. This can lead to increased urate burden and complications, including worsening kidn...
Center of the Target: Which Patients Are Most Likely to Develop Gout? 24.10.2023 5:00
Host: Richard Johnson, MD Guest: Abdul Abdellatif, MD, FASN This activity is no longer available for continuing education credit. Conventional oral urate-lowering therapies frequently to fail to achieve target serum uric acid (sUA) levels in patients with chronic kidney disease and uncontrolled refractory gout. This can lead to increased urate burden and complications, including worsening kidney d...
Is Managing Gout in the Nephrology Clinic a Challenge? 24.10.2023 4:30
Host: Richard Johnson, MD Guest: Abdul Abdellatif, MD, FASN This activity is no longer available for continuing education credit. Conventional oral urate-lowering therapies frequently to fail to achieve target serum uric acid (sUA) levels in patients with chronic kidney disease and uncontrolled refractory gout. This can lead to increased urate burden and complications, including worsening kidney d...
Is Gout Hiding in the Nephrology Clinic? 24.10.2023 5:00
Host: Abdul Abdellatif, MD, FASN Guest: Richard Johnson, MD This activity is no longer available for continuing education credit. Conventional oral urate-lowering therapies frequently to fail to achieve target serum uric acid (sUA) levels in patients with chronic kidney disease and uncontrolled refractory gout. This can lead to increased urate burden and complications, including worsening kidney d...
Gout Beyond the Joints: What’s the Hidden Danger? 24.10.2023 3:30
Host: Richard Johnson, MD This activity is no longer available for continuing education credit. Conventional oral urate-lowering therapies frequently to fail to achieve target serum uric acid (sUA) levels in patients with chronic kidney disease and uncontrolled refractory gout. This can lead to increased urate burden and complications, including worsening kidney disease, cardiovascular events, and...
Improving Symptoms in Patients with HFrEF Using Novel Device Therapy 07.08.2023 13:30
Host: Nirav Y. Raval, MD, FACC Guest: Gurusher Panjrath, MD, FACC, FAHA, FHFSA This program is no longer available for credit. Despite the use of guideline-directed medical therapy, many patients with heart failure continue to have worsening symptoms. Enter baroreflex activation therapy, or BAT, an implantable FDA-approved cardiac autonomic modulation device. Listen in as Drs. Nirav Raval and Guru...
Improving Symptoms in Patients with HFrEF Using Novel Device Therapy 07.08.2023 13:30
Host: Nirav Y. Raval, MD, FACC Guest: Gurusher Panjrath, MD, FACC, FAHA, FHFSA This program is no longer available for credit. Despite the use of guideline-directed medical therapy, many patients with heart failure continue to have worsening symptoms. Enter baroreflex activation therapy, or BAT, an implantable FDA-approved cardiac autonomic modulation device. Listen in as Drs. Nirav Raval and Guru...
Why Are the Fetus and Placenta Not Rejected by the Mother? New Insights Into Maternal Anti-Fetal Rejection 01.05.2023 14:00
Host: Lee P. Shulman, MD, FACMG, FACOG Guest: Roberto Romero, MD, DMedSci This program is no longer available for credit. Renowned international expert Dr. Roberto Romero joins Dr. Lee Shulman to walk us through maternal anti-fetal rejection. Find out about its pathophysiology, mechanisms of disease, approach to diagnosis, and potential treatment so that you can broaden your understanding and impr...
Why Are the Fetus and Placenta Not Rejected by the Mother? New Insights Into Maternal Anti-Fetal Rejection 01.05.2023 14:00
Host: Lee P. Shulman, MD, FACMG, FACOG Guest: Roberto Romero, MD, DMedSci This program is no longer available for credit. Renowned international expert Dr. Roberto Romero joins Dr. Lee Shulman to walk us through maternal anti-fetal rejection. Find out about its pathophysiology, mechanisms of disease, approach to diagnosis, and potential treatment so that you can broaden your understanding and impr...
Hasonló podcastok
Hallgasd a(z) CME/CE podcastot a Replaióban
Rádió és podcastok egy alkalmazásban - ingyen és regisztráció nélkül. Telepítsd még ma, és ne maradj le a premierről
A Replaio nem podcastkiadó; a műsorok nevei, borítóképei és hanganyagai a szerzőiket illetik, és nyilvános RSS-csatornákon keresztül terjednek.
